Our latest news, insights & events
Huge Congratulations to our long-standing client, Autobrains, a developer of first-of-its-kind self-learning artificial intelligence technology for assisted and autonomous driving,
Congratulations to our client Autobrains, for raising $101 million in Series C funding
Huge congratulations to our long-standing client, Augury, the leading Industrial IOT and AI-driven Machine Health solution provider, for securing $180
Congratulations to our client Augury for securing $180 million in a new funding round
Dear Clients and Colleagues, We are pleased to inform you that the final rules for foreign nationals to enter Israel
The final rules for foreign nationals to enter Israel as of November 1st
Our client, Biotech company Immunai inc., closed a major investment from Koch Disruptive Technologies as lead investor and other new
Our client Immunai inc. closed a major investment from Koch Disruptive Technologies as lead investor
According to studies about global warming, we have 21 years to save our planet. Do you want to be the
Energy Pioneers of Tomorrow
Dear Clients and Colleagues, We are happy to inform you of updates to the policy for entry into Israel. As
New Policy for Tourist and Entry into Israel
The French data protection supervisory authority (“CNIL”) has recently published a new white paper on payment data and means of
French Supervisory Authority Publishes White Paper re Means of Payment and Payment Data
Fintech deal-making has n-e-v-e-r been hotter. Coming out of the pandemic, fintechs have proven their value in a changed world
Fintech: Firing on All Cylinders
Technology & eCommerce Regulation in the Spotlight The Federal Trade Commission (“FTC”) has recently announced a widespread enforcement action against
FTC Puts More Than 700 Companies on Notice of Penalty Offenses for Endorsement Violations
Our client, BeeHero, already the 4th (!) largest pollination provider in the US, secured 19M$ in a new funding round.
Our client BeeHero secured 19M$ in a new funding round
Dear Clients and Colleagues, We would like to update you on the following subjects: A. Recognition of vaccinations given abroad and
